Literature DB >> 7829828

Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.

J Piniés1, L Castaño, P Colman.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7829828     DOI: 10.1007/bf03347748

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  7 in total

Review 1.  A molecular model of MHC class-I-restricted antigen processing.

Authors:  J J Monaco
Journal:  Immunol Today       Date:  1992-05

2.  Expression of intra-MHC transporter (Ham) genes and class I antigens in diabetes-susceptible NOD mice.

Authors:  H R Gaskins; J J Monaco; E H Leiter
Journal:  Science       Date:  1992-06-26       Impact factor: 47.728

3.  Linkage of faulty major histocompatibility complex class I to autoimmune diabetes.

Authors:  D Faustman; X P Li; H Y Lin; Y E Fu; G Eisenbarth; J Avruch; J Guo
Journal:  Science       Date:  1991-12-20       Impact factor: 47.728

4.  Linkage disequilibrium between TAP2 variants and HLA class II alleles; no primary association between TAP2 variants and insulin-dependent diabetes mellitus.

Authors:  K S Rønningen; D E Undlien; R Ploski; N Maouni; R J Konrad; E Jensen; E Hornes; H Reijonen; M Colonna; D S Monos
Journal:  Eur J Immunol       Date:  1993-05       Impact factor: 5.532

5.  Protection from insulin-dependent diabetes mellitus is linked to a peptide transporter gene.

Authors:  S Caillat-Zucman; E Bertin; J Timsit; C Boitard; R Assan; J F Bach
Journal:  Eur J Immunol       Date:  1993-08       Impact factor: 5.532

6.  Peptide translocation by variants of the transporter associated with antigen processing.

Authors:  M T Heemels; T N Schumacher; K Wonigeit; H L Ploegh
Journal:  Science       Date:  1993-12-24       Impact factor: 47.728

7.  Major histocompatibility complex-encoded antigen processing gene polymorphism in IDDM.

Authors:  P M van Endert; R S Liblau; S D Patel; L Fugger; T Lopez; F Pociot; J Nerup; H O McDevitt
Journal:  Diabetes       Date:  1994-01       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.